A Study of PRMT5 Inhibitor BAY 3713372 in Participants With MTAP-deleted Solid Tumors

Clinical trial NCT06914128 · RECRUITING

Trial details

NCT number: NCT06914128
Sponsor: Bayer
Status: RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

MTAP-deleted Solid Tumors

Start date: 2025-03-21
Primary completion: 2029-06-17
Enrollment: 450

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.